Robert Andrade
Chief Financial Officer, Phenix Pharmaceuticals
Replay available
Fennec Pharmaceuticals Inc. (FENC) Q1 2025 Earnings Call
Fennec Pharmaceuticals Inc. (NASDAQ: FENC) Q1 2025 earnings conference call, held 2025-05-13. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Jeff Hackman
Chief Executive Officer and Board Member, Phenix Pharmaceuticals
Chase Knickerbocker
Analyst
Sudan Loganathan
Analyst, Stephens
Michael Okunowich
Analyst, Maxim Group
Ram Selvaraju
Analyst, H.C. Wainwright
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Fennec Pharmaceuticals Inc..
Replay transcript excerpt
WEBVTT 00:00:00.071 -- 00:00:05.134 and only mode. Later, we will conduct a question and answer session, and instructions 00:00:05.134 -- 00:00:08.455 on how to participate will be given at that time. 00:00:08.455 -- 00:00:12.397 As a reminder, today's conference call is being recorded. 00:00:12.397 -- 00:00:17.520 Now, I would like to turn the conference over to Phenix Chief Financial Officer Robert 00:00:17.520 -- 00:00:19.520 Andrade. 00:00:20.502 -- 00:00:24.364 Thank you, Operator, and good morning, everyone. 00:00:24.364 -- 00:00:29.438 We appreciate you joining us today for Phenix Pharmaceutical's first quarter of 00:00:29.438 -- 00:00:31.090 2025 Earnings 00:00:31.090 -- 00:00:36.354 Conference Call, during which we will review our financial results as well 00:00:36.354 -- 00:00:39.777 as provide a general business update. 00:00:39.777 -- 00:00:45.581 Joining me from FENIC this morning is our Chief Executive Officer and Board Member, 00:00:45.581 -- 00:00:47.802 Jeff Hackman. 00:00:47.903 -- 00:00:51.746 Before we begin, I would like to remind you that during this call, the company will be 00:00:51.746 -- 00:00:56.811 making forward-looking statements that are subject to risks and uncertainties that may 00:00:56.811 -- 00:01:02.620 cause actual results to differ. from the results discussed in the forward-looking statements. 00:01:02.961 -- 00:01:07.682 Reference to these risks and uncertainties are made in today's press release and disclosed 00:01:07.682 -- 00:01:12.643 in detail in the company's periodic and current event filings with the U.S. 00:01:12.643 -- 00:01:15.704 Securities and Exchange Commission. 00:01:15.704 -- 00:01:20.885 In addition, any forward-looking statements made on this call represent our views 00:01:20.885 -- 00:01:26.286 only as of to...